Friday, April 12, 2024 11:01:15 PM
Joe is correct in a previous post. Gotta buy some more shares post RS if share count drops below desired minimum in hopes to participate in future rights offerings. Rights offerings are the only way shareholders can protect themselves from the excessive shorting and naked shorting occurring here. Im hoping Sonny will allow holders of previous rights/preferred shares to exchange those rights for new ones if there will be another rights offering.
========================================
Evidence showing Zimmer Biomet, or subsidiaries, was Sintx strategic partner for the development of Sintx femoral head for hip implants.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174227775
========================================
I post that Zimmer Biomet was in fact a strategic partner in regards to Sintx femoral head and true to form, Joe and Madg ignore that information in their posts focus instead on something we already knew was coming. Anything to distract i guess. Like the comment about Mask. Bashers treat mask IP as if it was a failure but it was mostly a success as the IP was developed and is free to commercialize with a much larger company than O2. Like maybe Sintx will supply 3M's medical spin off company (Solventum) where Zimmer Biomets former CEO Hanson landed for some licensing revenue for Zimmer Biomet? That spin off just completed along with ZimVies discount sale of its spinal assets.
Post style reflect both that of disinformation and bashing techniques.
https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/
https://fastercapital.com/content/Market-Hype--Unmasking-Stock-Bashers--Attempts-to-Manipulate-Buzz.html#Signs-to-Look-Out-For
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- SINTX AND PRODWAYS AGREE ON CERAMIC SLURRY SUPPLY AND 3D PRINTING AGREEMENT • GlobeNewswire Inc. • 04/29/2024 01:14:20 PM
- SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock • GlobeNewswire Inc. • 04/03/2024 01:00:00 PM
- SINTX Technologies Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/29/2024 08:00:00 PM
- SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock • GlobeNewswire Inc. • 03/25/2024 01:00:00 PM
- SINTX Technologies Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET • GlobeNewswire Inc. • 02/21/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 02:00:28 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:12:54 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/07/2024 09:42:32 PM
- SINTX Technologies Announces Closing of $4.0 Million Public Offering • GlobeNewswire Inc. • 02/02/2024 07:33:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 11:30:20 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/01/2024 10:14:28 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/01/2024 05:15:22 AM
- SINTX Technologies Announces Pricing of $4.0 Million Public Offering • GlobeNewswire Inc. • 01/31/2024 02:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 11:05:14 AM
- SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY • GlobeNewswire Inc. • 01/30/2024 09:01:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:16:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 02:05:13 PM
- SINTX TECHNOLOGIES SHARES SELECT PRELIMINARY Q4 2023 AND FULL YEAR 2023 REVENUE UPDATE • GlobeNewswire Inc. • 01/23/2024 02:00:00 PM
- SINTX TECHNOLOGIES SIGNIFICANTLY STRENGTHENS ITS ANTIPATHOGENIC PATENT PORTFOLIO • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 12:10:37 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/28/2023 09:44:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 03:10:10 PM
- SINTX TECHNOLOGIES ENTERS A LONG-TERM SUPPLY AGREEMENT FOR AEROSPACE COMPONENTS • GlobeNewswire Inc. • 11/07/2023 02:00:00 PM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM